Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines

4 Aug 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Research and Treatment
Share to vaccines and immunoinformatics approaches
Share to Virology and Viral Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19654066
DOI: 10.1016/j.vaccine.2009.07.039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccinesPMID 19654066Read ↗

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccineSemantic proximity Read ↗

Designing multivalent immunogens for alphavirus vaccine optimizationSemantic proximity Read ↗

Wanted, dead or alive: New viral vaccinesSemantic proximity Read ↗

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteersSemantic proximity Read ↗

HIV vaccine design: insights from live attenuated SIV vaccinesSemantic proximity Read ↗

Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation VaccinesSemantic proximity Read ↗

Design of a new multi-epitope subunit vaccine to combat the EIA virus, targeting Pol, Gag, and Env proteins: In silico techniqueSemantic proximity Read ↗

HIV-Host Interactions: Implications for Vaccine DesignSemantic proximity Read ↗

Recent strategies targeting HIV glycans in vaccine designSemantic proximity Read ↗

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical developmentSemantic proximity Read ↗

HIV-1 group M conserved elements vaccine.Semantic proximity Read ↗

HIV/AIDS Vaccines: 2018.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.